Johnson, A. S.; Arthur, H. M.; Burn, J.; Wilson, R. G.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA21
Academic Journal
A study has found that aspirin induces COX-2 independent endothelial cell apoptosis facilitating angiogenesis arrest, an important discovery for bowel cancer prevention. It was found that both aspirin and celecoxib caused dose dependent reduction in cell viability, proliferation and angiogenesis. Celecoxib produced these effects at levels in excess of normal serum levels when it is no longer COX-2 selective. Aspirin induces apoptosis via a COX-2 independent mechanism which may facilitate angiogenesis arrest and play a critical role in limiting tumour growth.


Related Articles

  • Prevention of colorectal cancer through the use of COX-2 selective inhibitors. Peek, Richard // Cancer Chemotherapy & Pharmacology. Supplement;Sep2004, Vol. 54, pS50 

    Colorectal cancer is a major cause of morbidity and mortality accounting for an estimated 550,000 deaths annually worldwide. Colonic neoplasia develops in a stepwise fashion progressing from normal mucosa to adenomatous polyps to carcinoma, a process that takes years, thereby providing a prime...

  • Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Langley, R E; Burdett, S; Tierney, J F; Cafferty, F; Parmar, M K B; Venning, G // British Journal of Cancer;10/11/2011, Vol. 105 Issue 8, p1107 

    Aspirin inhibits the enzyme cyclooxygenase (Cox), and there is a significant body of epidemiological evidence demonstrating that regular aspirin use is associated with a decreased incidence of developing cancer. Interest focussed on selective Cox-2 inhibitors both as cancer prevention agents and...

  • Effects of acetylsalicylic acid and celecoxib on the N-nitrosodiethylamine induced carcinogenesis in rat liver and esophagus. L. Bolieva; F. Dzhioev; S. Kakabadze // Bulletin of Experimental Biology & Medicine;Jan2007, Vol. 143 Issue 1, p87 

    Abstract  The effects of nonsteroid antiinflammatory drugs (acetylsalicylic acid and celecoxib) on N-nitrosodiethylamine-induced carcinogenesis in the liver and esophagus were studied in rats. The inhibitory effect of celecoxib on carcinogenesis was more pronounced (in comparison with...

  • Biology of Cox-2: An Application in Cancer Therapeutics. Khan, Zakir; Khan, Noor; Tiwari, Ram P.; Sah, Nand K.; Prasad, G. B. K. S.; Bisen, Prakash S. // Current Drug Targets;Jun2011, Vol. 12 Issue 7, p1082 

    No abstract available.

  • A New Cyclo-Oxygenase-2 Gene Variant in the Han Chinese Population is Associated with an Increased Risk of Gastric Carcinoma. Yumin Li; Wenting He; Tao Liu; Quanbao Zhang // Molecular Diagnosis & Therapy;Nov2010, Vol. 14 Issue 6, p351 

    Background and Objective: Cyclo-oxygenase-2 (COX-2, also known as prostaglandin synthase 2) influences carcinogenesis through regulation of angiogenesis, apoptosis, and cytokine expression. COX-2 is encoded by the gene PTGS2. Several studies have suggested that PTGS2 single-nucleotide...

  • Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease. Umemoto, Junichi; Tsurikisawa, Naomi; Nogi, Shinichi; Iwata, Kanako; Oshikata, Chiyako; Tatsuno, Sayaka; Tanimoto, Hidenori; Sekiya, Kiyoshi; Tsuburai, Takahiro; Mitomi, Hiroyuki; Akiyama, Kazuo // Allergy & Asthma Proceedings;May/Jun2011, Vol. 32 Issue 3, p259 

    Aspirin-induced asthma (AIA) is a severe and difficult-to-treat allergic disease in which acute asthma attacks are induced by nonsteroidal anti-inflammatory drugs. Patients with AIA rarely experience asthma attacks when taking celecoxib, a specific inhibitor of cyclooxygenase (COX) 2. A...

  • Inhibition of COX-2 in Colon Cancer Modulates Tumor Growth and MDR-1 Expression to Enhance Tumor Regression in Therapy-Refractory Cancers In Vivo. Rahman, Mahbuba; Selvarajan, Krithika; Hasan, Mohammad R.; Chan, Annie P.; Chaoyang Jin; Jieun Kim; Chan, Simon K.; Le, Nhu D.; Young-Bae Kim; Tai, Isabella T. // Neoplasia;Jul2012, Vol. 14 Issue 7, p624 

    Higher cyclooxygenase 2 (COX-2) expression is often observed in aggressive colorectal cancers (CRCs). Here, we attempt to examine the association between COX-2 expression in therapy-refractory CRC, how it affects chemo- sensitivity, and whether, in primary tumors, it is predictive of clinical...

  • A Structurally Optimized Celecoxib Derivative Inhibits Human Pancreatic Cancer Cell Growth. Li, Junan; Zhu, Jiuxiang; Melvin, W. Scott; Bekaii-Saab, Tanios S.; Chen, Ching-Shih; Muscarella, Peter // Journal of Gastrointestinal Surgery;Feb2006, Vol. 10 Issue 2, p207 

    Deregulation of the phosphatidylinositol 3-kinase (PI-3K)/PDK-l/Akt signaling cascade is associated with pancreatic cancer tumor invasion, angiogenesis, and tumor progression. As such, it has been postulated that PDK-1/Akt signaling inhibitors may hold promise as novel therapeutic agents for...

  • Death Receptor Regulation and Celecoxib-Induced Apoptosis.  // JNCI: Journal of the National Cancer Institute;12/1/2004, Vol. 96 Issue 23, p1727 

    Reports on the result of a study addressing the ability of celecoxib, a cyclooxygenase 2 inhibitor, to induce apoptosis in various cancer cell lines. Underlying mechanism of action; Cooperation of celecoxib with tumor necrosis factor-inducing ligand; Impact on DNA fragmentation.


Read the Article


Sign out of this library

Other Topics